RANZCP homepage
Date
23 June 2023
In June 2023 Scientia Professor Perminder Sachdev travelled to Tasmania from NSW as part of the Travelling Scholar program. He presented in various locations including Hobart, Launceston and Burnie.
A biomarker approach to diagnosing dementia
Burnie presentation
Neurodegenerative disorders, such as Alzheimer’s disease (AD), are defined as clinico-pathological entities in which a definitive diagnosis has traditionally been based on pathological hallmarks only available at autopsy. The development of biomarkers with high sensitivity and specificity has opened up the possibility of a definitive diagnosis in the clinical setting. Is a classification of neurodegenerative disorders based exclusively on biomarkers possible?
2023 Tasmania Travelling Scholar
Scientia Professor Perminder Sachdev
Perminder Sachdev AM, MBBS, MD, PhD, FRANZCP, FAAHMS is Scientia Professor of Neuropsychiatry at UNSW Sydney (UNSW), Co-Director of the Centre for Healthy Brain Ageing (CHeBA), UNSW, and Clinical Director of the Neuropsychiatric Institute, Prince of Wales Hospital in Sydney, Australia. His early work in Neuropsychiatry was on drug-induced movement disorders, in particular akathisia, tardive dyskinesia and neuroleptic malignant syndrome. His most recent work has been in dementia and pre-dementia syndromes, in particular relating to neuroimaging, neuropsychology, biomarkers and risk factors. He has extensively examined the outcome of psychosurgery and is currently involved in examining brain stimulation techniques (TMS, DCS, VNS and DBS) for psychiatric disorders.
In 2022 Prof Sachdev was awarded the Ryman Prize in recognition of research that has substantially enhanced the life of older people around the world. The Ryman Prize is the world's richest prize of its type and was established to create the equivalent of a Nobel Prize for people working in the field of the health of older people.
Perminder Sachdev AM, MBBS, MD, PhD, FRANZCP, FAAHMS is Scientia Professor of Neuropsychiatry at UNSW Sydney (UNSW), Co-Director of the Centre for Healthy Brain Ageing (CHeBA), UNSW, and Clinical Director of the Neuropsychiatric Institute, Prince of Wales Hospital in Sydney, Australia. His early work in Neuropsychiatry was on drug-induced movement disorders, in particular akathisia, tardive dyskinesia and neuroleptic malignant syndrome. His most recent work has been in dementia and pre-dementia syndromes, in particular relating to neuroimaging, neuropsychology, biomarkers and risk factors. He has extensively examined the outcome of psychosurgery and is currently involved in examining brain stimulation techniques (TMS, DCS, VNS and DBS) for psychiatric disorders.
In 2022 Prof Sachdev was awarded the Ryman Prize in recognition of research that has substantially enhanced the life of older people around the world. The Ryman Prize is the world's richest prize of its type and was established to create the equivalent of a Nobel Prize for people working in the field of the health of older people.
Disclaimer
This session is a Member benefit of the RANZCP and for educational purposes only. The information may represent views of the author and not necessarily the views of the College. Information is subject to change and the College does not warrant that the information is current at the time of viewing and accepts no liability for any loss or damage suffered by you or a patient directly or indirectly as a result of relying on information provided and should not be a substitute for individual clinical judgement. By accessing e-learning sessions you also agree to the RANZCP Website Terms of Use Agreement.
